Emerging therapeutic targets for the treatment of nicotine addiction (Q38473341)

3 September 2017

title

Emerging therapeutic targets for the treatment of nicotine addiction (English)

1 reference

3 September 2017

Paul J Kenny

1

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

Expert Review of Clinical Pharmacology

3 September 2017

published in

1 reference

3 September 2017

volume

2

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

221-225

1 reference

The scientific case that nicotine is addictive.

3 September 2017

cites work

1 reference

The concepts of the ventral striatopallidal system and extended amygdala

21 January 2018

1 reference

Nicotine: from molecular mechanisms to behaviour

21 January 2018

1 reference

NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala

21 January 2018

1 reference

Nicotine psychopharmacology: addiction, cognition and neuroadaptation

21 January 2018

1 reference

Neuropharmacology and potential efficacy of new treatments for tobacco dependence

21 January 2018

1 reference

Smoking cessation: lessons learned from clinical trial evidence

21 January 2018

1 reference

Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine

21 January 2018

1 reference

Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats

21 January 2018

1 reference

Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats.

21 January 2018

1 reference

The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats

21 January 2018

1 reference

Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats

21 January 2018

1 reference

The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice

21 January 2018

1 reference

Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice

21 January 2018

1 reference

Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence

21 January 2018

1 reference

The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions

21 January 2018

1 reference

Striatal dopamine D2/D3 receptor availability in male smokers

21 January 2018

1 reference

The dopamine D3 receptor and drug dependence: effects on reward or beyond?

21 January 2018

1 reference

Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior

21 January 2018

1 reference

Disruption of nicotine conditioning by dopamine D(3) receptor ligands

21 January 2018

1 reference

Accruing preclinical evidence about metabotropic glutamate 5 receptor antagonists as treatments for drug dependence highlights the irreplaceable contributions of animal studies to the discovery of new medications for human disorders

21 January 2018

1 reference

Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status

21 January 2018

1 reference

Non-nicotinic therapies for smoking cessation.

21 January 2018

1 reference

CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.

21 January 2018

1 reference

Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy

21 January 2018

1 reference

Nicotine metabolism defect reduces smoking

21 January 2018

1 reference

Investigations using immunization to attenuate the psychoactive effects of nicotine

21 January 2018

1 reference

Insular hypocretin transmission regulates nicotine reward

21 January 2018

1 reference

CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats

21 January 2018

1 reference

Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence.

21 January 2018

1 reference

Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats

21 January 2018

1 reference

Disrupting reconsolidation of conditioned withdrawal memories in the basolateral amygdala reduces suppression of heroin seeking in rats.

21 January 2018

1 reference

Cue-induced cocaine seeking and relapse are reduced by disruption of drug memory reconsolidation.

21 January 2018

1 reference

Disrupting reconsolidation of drug memories reduces cocaine-seeking behavior.

21 January 2018

1 reference

Independent cellular processes for hippocampal memory consolidation and reconsolidation

21 January 2018

1 reference

Beyond extinction: erasing human fear responses and preventing the return of fear

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECP.09.6

1 reference

3 September 2017

1 reference